We tested the EGFR mutation status in 253 FFPE NSCLC specimens (a subset of 452 total cases) using both OncoAim and ARMS-PCR (Amplification refractory mutation system-Polymerase Chain Reaction) technique. Here, EGFR is linked to non-small cell lung carcinoma.